Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”

Quick Read

This Pharma Exec Is Accused Of Fixing Prices On 107 Drugs

Quick Read

Patients who experience organ failure need a transplant to improve their odds of survival and to achieve a better quality of life

Quick Read

The War to Free Science

June 11, 2019

How librarians, pirates, and funders are liberating the world’s academic research from paywalls

Quick Read

Just 50 years ago, some 1,000 small and family-owned seed companies were producing and distributing seeds in the United States; by 2009, there were fewer than 100. Thanks to a series of mergers and acquisitions over the last few years, four multinational agrochemical firms now control over 60 percent of global seed sales

Quick Read

Many patients like Bacon struggle to get insurance coverage for their mental health treatment, even though two federal laws were designed to bring parity between mental and physical health care coverage. Recent studies and a legal case suggest serious disparities remain

Quick Read

As someone who has lived with spinal muscular atrophy for all 30 years of my life, I was perplexed and disappointed that the recent approval of Novartis’ gene therapy Zolgensma was immediately overshadowed by outrage over the drug’s price: $2.125 million

Quick Read

Congress wants a single ALS patient to get a therapy never tested in humans. A family in Iowa believes the Food and Drug Administration will decide whether their only surviving daughter lives or dies, and they’ve been on a monthslong crusade to break through its bureaucracy. And they’re succeeding

Quick Read